Nephrology, Dialysis and Transplantation Unit and CNR-IBIM, Reggio Calabria, Italy.
Blood Purif. 2013;36(1):58-62. doi: 10.1159/000351004. Epub 2013 May 25.
'Usual' blood pressure (BP) levels are known to be directly related to cardiovascular (CV) risk in the general population and patients with essential hypertension. However, there is increasing evidence that, apart from usual BP, BP variability across visits may also be an important risk factor for death and CV events in healthy subjects and in essential hypertensive patients. In chronic kidney disease (CKD) patients the relationship between hypertension and clinical outcome is still controversial. Moreover, high visit-to-visit BP variability was very recently found to predict death and CV events in this high-risk patient population. This review focuses on the available evidence about the link between high visit-to-visit BP variability and clinical outcomes in CKD patients and describes some hypothetical mechanisms that could explain such a relationship.
“通常”的血压(BP)水平已知与普通人群和原发性高血压患者的心血管(CV)风险直接相关。然而,越来越多的证据表明,除了通常的 BP 之外,就诊时的 BP 变异性也可能是健康受试者和原发性高血压患者死亡和 CV 事件的重要危险因素。在慢性肾脏病(CKD)患者中,高血压与临床结局之间的关系仍存在争议。此外,最近发现高就诊间 BP 变异性可预测该高危患者人群的死亡和 CV 事件。这篇综述重点介绍了高就诊间 BP 变异性与 CKD 患者临床结局之间关联的现有证据,并描述了一些可以解释这种关系的假设机制。